Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginseng for sexual function in postmenopausal women with major depression
IRCT20120718010324N74Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ginseng in major depressive disorder (MDD) and female sexual dysfunction (FSD), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Sexual function improvement. Started Dec 2022; status: completed.
02
Drugs
ginseng
03
Conditions
major depressive disorder (MDD)female sexual dysfunction (FSD)
Beyond the preview
Go deeper on IRCT20120718010324N74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120718010324N74.